The shared 199 transcriptional data set was investigated in the Porto Cohort of prostate cancer patients, where patients are either categorised as “Cases”, those that developed BCR, or “Control”, those that did not develop BCR [43]. The gene discussed is BCR; the disease is Familial prostate cancer.